Smith Gregory Stephen sold $1.7M of TER

Smith Gregory Stephen (President and CEO) sold 4,000 shares of TERADYNE, INC (TER) at $425.00 ($1.70M total) on 2026-08-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Gregory Stephen
Published Aug 18, 2026, 3:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 4:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TER
Neutral
high confidence
Mentioned
$TER
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

The only new information is the disclosed sale size, price, and post-transaction holdings; it does not include any new guidance, contract, or regulatory development.

02

Market read

Traders may note the CEO’s scheduled sale optics, but there is no fundamental update to drive repricing.

03

What to watch

The disclosure does not indicate whether the sale was driven by diversification, taxes, or scheduled liquidity needs; 10b5-1 timing can decouple sales from near-term outlook.

Relevance 5/10Novelty 3/10Timing: filed today on SEC EDGAR, covering a sale dated 2026-08-17

Background

The article is an SEC Form 4 insider transaction report for Teradyne, Inc. (TER) by its President and CEO.

Company-level read

Ticker impact

$TERNeutralHigh confidence
Context

Teradyne CEO sold 4,000 shares in an open-market transaction for about $1.7M under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is more about optics than fundamentals.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan, and the article provides no new company-specific operational or financial information.

Market effects

No direct sector read-through; insider sales under 10b5-1 are typically not interpreted as earnings or guidance signals.

None.

None.

Counterpoint

Some traders may treat large CEO sales as a mild bearish signal, even if 10b5-1 reduces interpretability.

Key entities

  • TERADYNE, INC

    Public company whose CEO filed the Form 4 insider sale disclosure.

  • Smith Gregory Stephen

    President and CEO who sold 4,000 shares at $425/share under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TERHigh

Teradyne and FormFactor jump after Jefferies starts coverage with Buy ratings

Jefferies initiated coverage of Teradyne and FormFactor with Buy ratings, citing their roles in AI-driven chip testing. Teradyne's stock rose 8.3% to $265.78, with a $284 target, while FormFactor gained 11.9% with a $102 target. Jefferies projects significant growth in the automated test equipment market, with Teradyne's revenue potentially rising from $1.9B to $6.9B by 2030. Both companies have seen recent pullbacks but reported strong AI-related revenue growth.

$TERHigh

Teradyne's AI testing opportunity prompts Jefferies 'buy' rating

Jefferies initiated coverage of Teradyne (NYSE:TER) with a Buy rating and $284 price target, citing AI-driven demand. The broker forecasts semiconductor testing market growth to $25B by 2030, with Teradyne's SoC testing revenue rising to $6.9B. Teradyne's shares fell 53% from summer highs, which Jefferies sees as an entry point. The bank expects Teradyne to gain market share and benefit from Nvidia's (NASDAQ:NVDA) adoption of dual sourcing.

$TERHigh

Why is Teradyne stock surging today?

Teradyne (TER) stock rose 8% in pre-market trading after Jefferies initiated coverage with a Buy rating and $284 price target, citing AI-driven growth. Analysts expect the semiconductor test equipment market to expand significantly, with TER benefiting from increased system-on-chip testing. The company's Q3 2026 earnings beat consensus, and broader tech sector gains also supported the surge.